期刊文献+

Ⅱ期结直肠癌高危因素及辅助化疗的必要性探讨 被引量:4

Identification of high-risk factors and necessity of adjuvant chemotherapy for stage Ⅱ colorectal cancer
下载PDF
导出
摘要 目的分析影响Ⅱ期结直肠癌患者预后的高危因素,初步探讨具有高危因素的患者行辅助化疗的必要性。方法对443例行结直肠癌根治术的Ⅱ期结直肠癌患者的临床病理资料进行统计,用Kaplan-Meier法计算生存率、绘制生存曲线。对高危因素进行Cox单因素和多因素模型分析,具有高危因素的患者再按有无辅助化疗分组分析、比较预后。结果术前伴有肠梗阻或穿孔、送检淋巴结数少于12枚、T4分期、切缘小于1 cm是影响Ⅱ期结直肠癌患者预后的高危因素,分组分析显示术前伴有肠梗阻或穿孔、送检淋巴结数少于12枚、T4分期的Ⅱ期大肠癌患者行辅助化疗后总生存率高于未化疗者。结论术前伴有肠梗阻或穿孔、送检淋巴结数少于12枚、T4分期、切缘小于1 cm是Ⅱ期结直肠癌患者预后不良的高危因素,具有前3种高危因素的患者可能从辅助化疗中获益。 Objective To identify the high risk factors in the prognosis of stage Ⅱ colorectal cancer, and analyze the necessity of adjuvant chemotherapy. Methods Four hundred and forty three patients with stage Ⅱcolon cancer who had received radical surgery in cancer center of Sun Yat - sen University were retrospectively analyzed. The overall surviv- al rate and survival curve were analyzed with the Kaplan - Meier method and Log - rank test, respectively. The univariate and multivariate Cox regression model were applied for high risk factors analysis. For patients with high - risk factors, prognosis was compared between patients with or without adjuvant chemotherapy. Results Univariate and multivariate regression analysis revealed that preoperative intestinal obstruction or perforation, number of sampled nodes less than 12, T4 stage and inadequate surgical margin were independent unfavorable prognostic factors for patient survival with stage Ⅱ colorectal cancer. During subgroup analysis, patients with the first three high - risk factors had higher 3 - year and 5 - year overall survival with adjuvant chemotherapy. Conclusion Preoperative intestinal obstruction or perforation, number of sampled nodes less than 12, T4 stage and inadequate surgical margin were high - risk prognostic factors. Furhtermore, patients with the first three factors can benefit from adjuvant chemotherapy.
出处 《广东医学》 CAS CSCD 北大核心 2010年第1期69-71,共3页 Guangdong Medical Journal
基金 广东省科技计划项目(编号:2008B030301119) 广东省医学科研基金项目(编号:B2007071 B2008057)
关键词 结直肠癌 Ⅱ期 高危因素 化疗 colorectal cancer Ⅱ stage high risk factor chemotherapy
  • 相关文献

参考文献1

二级参考文献15

  • 1[1]Zaheer S,Pemberton JH,Farouk R,Dozois RR,Wolff BG,Ilstrup D.Surgical treatment of adenocarcinoma of the rectum.Ann Surg 1998; 227:800-811
  • 2[2]Goligher JC,Dukes CE,Bussey HJ.Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid.Br J Surg 1951; 39:199-211
  • 3[3]Vernava AM 3rd,Moran M,Rothenberger DA,Wong WD.A prospective evaluation of distal margins in carcinoma of the rectum.Surg Gynecol Obstet 1992; 175:333-336
  • 4[4]Shirouzu K,Isomoto H,Kakegawa T.Distal spread of rectal cancer and optimal distal margin of resection for sphincterpreserving surgery.Cancer 1995; 76:388-392
  • 5[5]Moore HG,Riedel E,Minsky BD,Saltz L,Paty P,Wong D,Cohen AM,Guillem JG.Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.Ann Surg Oncol 2003; 10:80-85
  • 6[6]Takayama O,Yamamoto H,Ikeda K,Ishida H,Kato T,Okuyama M,Kanou T,Fukunaga M,Tominaga S,Morita S,Fujie Y,Fukunaga H,Ikenaga M,Ikeda M,Ohue M,Sekimoto M,Kikkawa N,Monden M.Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer:A translational research study.Int J Oncol 2004; 25:597-604
  • 7[7]Sondenaa K,Kjellevold KH.A prospective study of the length of the distal margin after low anterior resection for rectal cancer.Int J Colorectal Dis 1990; 5:103-105
  • 8[8]Baker SJ,Preisinger AC,Jessup JM,Paraskeva C,Markowitz S,Willson JK,Hamilton S,Vogelstein B.p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.Cancer Res 1990; 50:7717-7722
  • 9[9]Brennan JA,Mao L,Hruban RH,Boyle JO,Eby YJ,Koch WM,Goodman SN,Sidransky D.Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.N Engl J Med 1995; 332:429-435
  • 10[10]Hayashi N,Ito I,Yanagisawa A,Kato Y,Nakamori S,Imaoka S,Watanabe H,Ogawa M,Nakamura Y.Genetic diagnosis of lymph-node metastasis in colorectal cancer.Lancet 1995; 345:1257-1259

共引文献9

同被引文献47

  • 1Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage ]I or NI colon cancer in the MOSAIC trial[J]. J Clin Oncol, 2009, 27 (19) :3109--3116.
  • 2Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adju- vant therapy in colon cancer: observations based on individual pa- tient data from 20,898 patients on 18 randomized trials[J]. J Clin Oncol, 2009, 27(6):872--877.
  • 3Gray R, BarnweU J, Mcconkey C, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study[J]. Lancet, 2007, 370(9604):2020-2029.
  • 4O'ConnellJB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth editionstaging[J].J Natl Cancer Inst, 2004, 96(19):1420-1425.
  • 5Benson AR, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage colon cancer[J].J Clin Oncol, 2004, 22(16):3408--3419.
  • 6O'Gonnor ES, Greenblatt D Y, Loconte NK, et al. Adjuvant chemo- therapy for stage ]] colon cancer with poor prognostic features[J].J Clin Oncol, 2011, 29(25) :3381-3388.
  • 7Kim GP, Colangelo LH, Wieand HS, et al. Prognostic and predic- five roles of high-degree microsateUite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study[J]. J Clin Oncol, 2007, 25(7): 767--772.
  • 8Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer[J].J Clin Oncol, 2010, 28(20):3219-3226.
  • 9Hutchins G, Southward K, Handley K, et al. Value of mismatch re- pair, KRAS, and BRAF mutations in predicting recurrence and ben- efits from chemotherapy in colorectal cancer.J Clin Oncol, 2011, 29(10):1261-1270.
  • 10Merkel S, Wein A, Gunther K, et al. High-risk groups of patients with Stage colon carcinoma[J]. Cancer, 2001, 92(6):1435-1443.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部